312 related articles for article (PubMed ID: 16513293)
21. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
22. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
[TBL] [Abstract][Full Text] [Related]
23. RANK- NFATc1 signaling forms positive feedback loop on rank gene expression via functional NFATc1 responsive element in rank gene promoter.
Kitazawa R; Haraguchi R; Kohara Y; Kitazawa S
Biochem Biophys Res Commun; 2021 Oct; 572():86-91. PubMed ID: 34358968
[TBL] [Abstract][Full Text] [Related]
24. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
[TBL] [Abstract][Full Text] [Related]
25. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
26. Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation.
Kim HH; Chung WJ; Lee SW; Chung PJ; You JW; Kwon HJ; Tanaka S; Lee ZH
Exp Cell Res; 2003 Oct; 289(2):368-77. PubMed ID: 14499638
[TBL] [Abstract][Full Text] [Related]
27. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
[TBL] [Abstract][Full Text] [Related]
28. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.
Kim JH; Kim K; Youn BU; Jin HM; Kim N
Cell Signal; 2010 Sep; 22(9):1341-9. PubMed ID: 20466061
[TBL] [Abstract][Full Text] [Related]
29. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
30. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway.
Huang H; Chang EJ; Ryu J; Lee ZH; Lee Y; Kim HH
Biochem Biophys Res Commun; 2006 Dec; 351(1):99-105. PubMed ID: 17052691
[TBL] [Abstract][Full Text] [Related]
31. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.
Kim Y; Sato K; Asagiri M; Morita I; Soma K; Takayanagi H
J Biol Chem; 2005 Sep; 280(38):32905-13. PubMed ID: 16046394
[TBL] [Abstract][Full Text] [Related]
32. Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation.
Liu Y; Shi Z; Silveira A; Liu J; Sawadogo M; Yang H; Feng X
J Biol Chem; 2003 Jun; 278(23):20603-11. PubMed ID: 12663664
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.
Matsuo K; Galson DL; Zhao C; Peng L; Laplace C; Wang KZ; Bachler MA; Amano H; Aburatani H; Ishikawa H; Wagner EF
J Biol Chem; 2004 Jun; 279(25):26475-80. PubMed ID: 15073183
[TBL] [Abstract][Full Text] [Related]
34. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells.
Hirotani H; Tuohy NA; Woo JT; Stern PH; Clipstone NA
J Biol Chem; 2004 Apr; 279(14):13984-92. PubMed ID: 14722106
[TBL] [Abstract][Full Text] [Related]
35. RANK-L induces the expression of NFATc1, but not of NFkappaB subunits during osteoclast formation.
Zhu LL; Zaidi S; Moonga BS; Troen BR; Sun L
Biochem Biophys Res Commun; 2005 Jan; 326(1):131-5. PubMed ID: 15567162
[TBL] [Abstract][Full Text] [Related]
36. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N
FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
38. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts.
Sun L; Peng Y; Zaidi N; Zhu LL; Iqbal J; Yamoah K; Wang X; Liu P; Abe E; Moonga BS; Epstein S; Zaidi M
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F285-91. PubMed ID: 16968888
[TBL] [Abstract][Full Text] [Related]
39. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
Kitazawa R; Kitazawa S
Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]